- Home
- PROK vs ASLE Comparison
PROK vs ASLE Comparison
Compare PROK & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- ASLE
- Stock Information
- Founded
- PROK 2015
- ASLE 2008
- Country
- PROK United States
- ASLE United States
- Employees
- PROK N/A
- ASLE N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- ASLE Industrial Specialties
- Sector
- PROK Health Care
- ASLE Consumer Discretionary
- Exchange
- PROK Nasdaq
- ASLE Nasdaq
- Market Cap
- PROK 271.2M
- ASLE 276.1M
- IPO Year
- PROK N/A
- ASLE N/A
- Fundamental
- Price
- PROK $2.33
- ASLE $4.91
- Analyst Decision
- PROK Buy
- ASLE Strong Buy
- Analyst Count
- PROK 3
- ASLE 3
- Target Price
- PROK $4.00
- ASLE $9.67
- AVG Volume (30 Days)
- PROK 372.7K
- ASLE 337.9K
- Earning Date
- PROK 08-09-2024
- ASLE 08-07-2024
- Dividend Yield
- PROK N/A
- ASLE N/A
- EPS Growth
- PROK N/A
- ASLE N/A
- EPS
- PROK N/A
- ASLE N/A
- Revenue
- PROK N/A
- ASLE $354,547,000.00
- Revenue This Year
- PROK N/A
- ASLE $10.81
- Revenue Next Year
- PROK N/A
- ASLE $19.15
- P/E Ratio
- PROK N/A
- ASLE N/A
- Revenue Growth
- PROK N/A
- ASLE 20.71
- 52 Week Low
- PROK $1.12
- ASLE $4.70
- 52 Week High
- PROK $8.56
- ASLE $16.69
- Technical
- Relative Strength Index (RSI)
- PROK 51.06
- ASLE 38.44
- Support Level
- PROK $2.07
- ASLE $4.70
- Resistance Level
- PROK $2.45
- ASLE $5.18
- Average True Range (ATR)
- PROK 0.17
- ASLE 0.22
- MACD
- PROK 0.01
- ASLE 0.04
- Stochastic Oscillator
- PROK 68.42
- ASLE 31.82
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.